Aminoquinoxaline derivatives for treatment of neurodegenerative diseases

The present invention relates to compounds of formula (I) below: for which: -X represents a hydrogen atom, a halogen atom, a group NO2 or NH2, -R0 represents H or -CH2-C≡CH, and -R1 and R2 each represent, independently of one another, a hydrogen atom; a saturated or unsaturated, linear or branched h...

Full description

Saved in:
Bibliographic Details
Main Authors Le Douaron Gaël, Ferrie Laurent, Raisman-Vozari Rita, Figadere Bruno, Schmidt Fanny
Format Patent
LanguageEnglish
Published 06.09.2016
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to compounds of formula (I) below: for which: -X represents a hydrogen atom, a halogen atom, a group NO2 or NH2, -R0 represents H or -CH2-C≡CH, and -R1 and R2 each represent, independently of one another, a hydrogen atom; a saturated or unsaturated, linear or branched hydrocarbon-based chain comprising from 1 to 10 carbon atoms; or an optionally substituted aryl group, and also the pharmaceutically acceptable salts thereof, the stereoisomers thereof or mixtures of stereoisomers thereof in any proportion, in particular for use thereof as a medicament, in particular in the treatment or prevention of neurodegenerative diseases, and also the processes for the preparation thereof and the pharmaceutical compositions comprising same.
Bibliography:Application Number: US201214008189